Reuters logo
BRIEF-Recce Confirms Pre-IND data submission to US FDA for its lead antibiotic candidate
September 6, 2017 / 11:54 PM / 3 months ago

BRIEF-Recce Confirms Pre-IND data submission to US FDA for its lead antibiotic candidate

Sept 7 (Reuters) - Recce Ltd

* Confirms pre-ind data submission to US FDA for its lead antibiotic candidate

* It is expected there will be at least one more submission of data to support final ind application for approval to begin human trials Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below